These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 2529079)

  • 1. [Clinical functional study of a new delayed-action preparation of "once a day" anhydrous theophylline in patients with chronic obstructive bronchopneumopathy].
    Gatto PG; Bruzzoni A; Valenti V
    Clin Ter; 1989 Jul; 130(1):45-9. PubMed ID: 2529079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinico-laboratory evaluation a new sustained-release preparation of anhydrous theophylline].
    Gandola L; Aiolfi S; Soccini F; Patrini G; Capellini G; Scartabellati A; Ghio L; Mauri F
    Clin Ter; 1989 Dec; 131(5):293-7. PubMed ID: 2532583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The comparative efficacy of the prolonged-action theophylline preparations Theopek and Euphylong in elderly patients with chronic obstructive lung diseases].
    Salikova VV; Nonikov VE; Belousov IuB
    Ter Arkh; 1993; 65(8):41-4. PubMed ID: 8211801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical effectiveness of delayed-action theophylline preparations].
    Tsoĭ AN; Gavrilenko LN; Bogovskiĭ BP; Semenova LG; Iuldasheva LI
    Klin Med (Mosk); 1990 Sep; 68(9):72-5. PubMed ID: 2290338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Bamifylline in the treatment of chronic bronchial obstruction: a controlled clinico-functional study versus an anhydrous theophylline administered once a day].
    Caputi M; Cautiero V; Aliberti M; Monici Preti PA; Oliani C
    Arch Monaldi Mal Torace; 1988; 43(5):409-21. PubMed ID: 3079283
    [No Abstract]   [Full Text] [Related]  

  • 6. [Comparison of two long-acting theophylline preparations in daily evening administration].
    Holzer R
    Wien Med Wochenschr; 1993; 143(2):37-42. PubMed ID: 8488685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative dose study of a theophylline sustained-release tablet formulation after repeated administrations.
    Cova D; Cuglituri G; Rossini L; Bonfardeci G
    Int J Clin Pharmacol Ther Toxicol; 1989 Jun; 27(6):273-5. PubMed ID: 2737795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Tolerance of a new oral long-acting theophylline in patients with obstructive airway diseases].
    Nolte D; Dusik B
    Fortschr Med; 1983 Jul; 101(25):1203-6. PubMed ID: 6884955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-acting versus a long-acting preparation of theophylline ('Xantivent') in the treatment of reversible bronchospasm.
    Andrasch R; Schmitz-Schumann M
    Pharmatherapeutica; 1984; 3(10):668-77. PubMed ID: 6463066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prescription of Theostat 300 as a single evening dose].
    Germouty J; Bida C; Moreau L
    Rev Pneumol Clin; 1987; 43(5):262-5. PubMed ID: 3324266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Results of a serum concentration-oriented dosage of a theophylline depot preparation in ambulatory patients with chronic obstructive lung disease].
    Harder S; Staib AH; Stauder J
    Prax Klin Pneumol; 1985 Jun; 39(6):193-6. PubMed ID: 4022931
    [No Abstract]   [Full Text] [Related]  

  • 12. [Use of a new delayed-release anhydrous theophylline by single daily administration in the treatment of reversible bronchial obstruction. Comparison with a delayed-release preparation administered twice daily].
    Baronti A; Verdiani P; Di Carlo S
    Clin Ter; 1987 Sep; 122(6):437-40. PubMed ID: 2972456
    [No Abstract]   [Full Text] [Related]  

  • 13. Long-term therapy with sustained-release theophylline.
    Myhre KI; Arnulf V; Walstad RA
    Pharmatherapeutica; 1985; 4(2):92-7. PubMed ID: 3903782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical results obtained from a new controlled release theophylline preparation.
    Nolte D
    Br J Clin Pract Suppl; 1984; 32():14-7. PubMed ID: 6432017
    [No Abstract]   [Full Text] [Related]  

  • 15. [Levels of blood theophylline in patients with acute bronchospasm].
    Martínez MJ; Martínez B; Saucedo R; García Delgado R; García Morillas M; Puche E
    Rev Clin Esp; 1989 May; 184(9):470-2. PubMed ID: 2772324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Euphylong in patients with chronic obstructive airway diseases].
    Kublik A; von Wichert P
    Pneumologie; 1991 Nov; 45 Suppl 4():858-62. PubMed ID: 1812480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the effectiveness and safety of a controlled-release theophylline in patients with reversible and stable bronchial obstruction.
    Grassi V; Nicora M; Beretta A
    Int J Clin Pharmacol Res; 1987; 7(5):337-44. PubMed ID: 3667006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum theophylline concentrations and pulmonary function tests after administration of two sustained-release formulations containing theophylline in patients affected by chronic obstructive lung disease.
    Fontana G; Cresci F; Lo Sapio P; Panuccio P
    Int J Clin Pharmacol Res; 1987; 7(5):351-6. PubMed ID: 3667008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of theophylline on cortisol plasma concentrations in patients with chronic obstructive pulmonary disease.
    Gimeno F; Steenhuis EJ; Jonkman JH
    Int J Clin Pharmacol Ther Toxicol; 1990 Apr; 28(4):139-43. PubMed ID: 2187001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of reversible chronic airways obstruction with doxofylline compared with slow-release theophylline: a double-blind, randomized, multicentre trial.
    Melillo G; Balzano G; Jodice F; De Felice A; Campisi V; Capone M; Di Filippo A; Foddai G; Franzone JS; Grossi E
    Int J Clin Pharmacol Res; 1989; 9(6):397-405. PubMed ID: 2699466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.